Log in to save to my catalogue

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8672712

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

About this item

Full title

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2021-11, Vol.385 (21), p.1961-1973

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

At a median follow-up of 3.5 years after gene therapy with a factor VIII–containing adeno-associated virus, 16 of 18 men with hemophilia A had enough factor VIII expression that bleeding events were reduced to nearly zero and prophylaxis was discontinued. Vector-related hepatitis led to elimination of the vector in 2 men, but immunosuppressive ther...

Alternative Titles

Full title

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8672712

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8672712

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2104205

How to access this item